Toggle Main Menu Toggle Search

Open Access padlockePrints

Clinical practice guidelines for older people with multi-morbidity and life limiting illness: what are the implications for deprescribing?

Lookup NU author(s): Dr Daniel OkeowoORCiD, Professor Adam ToddORCiD

Downloads


Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Sage Publications Ltd., 2018.

For re-use rights please refer to the publisher's terms and conditions.


Abstract

Objectives:To apply current NICE clinical practice guidelines to a hypothetical older patient with multi-morbidity and life limiting illness; (2) consider how treatment choices could be influenced by NICE guidance specifically related to multimorbidity; and, (3) ascertain if such clinical practice guidelines describe how and when medication should be reviewed, reduced and stopped. Methods:Based upon common long-term conditions in older people, a hypothetical older patient was constructed. Relevant NICE guidelines were applied to the hypothetical patient to determine what medication should be initiated in three treatment models: a new patient model, a treatment resistant model, and a last line model. Medication complexity for each model was assessed according to the medication regimen complexity index (MRCI). Results:The majority of the guidelines recommended the initiation of medication in the hypothetical patient; if the initial treatment approach was unsuccessful, each guideline advocated the use of more medication – with the regimen becoming increasingly complex. In the new patient model, 4 separate medications (9 dosage units) would be initiated per day; for the treatment resistant model, 6 separate medications (15 dosage units); and, for the last line model, 11 separate medications (20 dosage units). None of the guidelines used for the hypothetical patient discussed approaches to stopping medication. Conclusions:In a UK context, disease specific clinical practice guidelines routinely advocate the initiation of medication to manage long-term conditions, with medication regimens becoming increasingly complex through the different steps of care. There is often a lack of information regarding specific treatment recommendations for older people with life limiting illness and multi-morbidity. While guidelines frequently explain how and when a medication should be initiated, there is often no information concerning when the medications should be reduced or stopped.


Publication metadata

Author(s): Okeowo D, Patterson A, Boyd C, Reeve E, Gnjidic D, Todd A

Publication type: Article

Publication status: Published

Journal: Therapeutic Advances in Drug Safety

Year: 2018

Volume: 9

Issue: 11

Pages: 619-630

Print publication date: 01/11/2018

Online publication date: 12/09/2018

Acceptance date: 02/07/2018

Date deposited: 04/07/2018

ISSN (print): 2042-0986

ISSN (electronic): 2042-0994

Publisher: Sage Publications Ltd.

URL: https://doi.org/10.1177/2042098618795770

DOI: 10.1177/2042098618795770


Altmetrics

Altmetrics provided by Altmetric


Share